Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evening Exercise Insulin Reduction in Type 1 Diabetes
NCT02204839Completed
- Sponsor
- Northumbria University
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of insulin glargine and insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Northumbria University. Primary endpoint: 24 hour blood glucose area under the curve. Started Jan 2014; status: completed.
02
Drugs
insulin glargineinsulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02204839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02204839.